Moderna ( 
MRNA ) looks to be a rebounding stock specializing in RNA therapeutics. Their net income and net margin looks to be in the positive for next earnings by Feb 13th. Their Debt-To-Equity ratio is only 4.2% as per Forbes (https://www.forbes.com/sites/greatspeculations/2026/01/22/whats-happening-with-moderna-stock/) compared to other S&P stocks. Their stock looks to be bouncing back after loss of demand from the Covid Vaccine. Anti-vaccine rhetoric in the United States by the Government and it's supporters makes the future wary for vaccine stocks like MRNA , but I am entering a trade here based on the fact that their net income may be positive for next quarter, and it will be moreso of a long term trade spanning a couple of months. The lowest that I think it can rise to is $60, but it could go higher than that. Who knows. Worst Case is that It will go back down into to $20-30 range, but then again I am still optimistic that ( MRNA ) can turn things around. So we'll see. My cost basis for this trade is around 48.5, so that's alright for this stock.
MRNA ) looks to be a rebounding stock specializing in RNA therapeutics. Their net income and net margin looks to be in the positive for next earnings by Feb 13th. Their Debt-To-Equity ratio is only 4.2% as per Forbes (https://www.forbes.com/sites/greatspeculations/2026/01/22/whats-happening-with-moderna-stock/) compared to other S&P stocks. Their stock looks to be bouncing back after loss of demand from the Covid Vaccine. Anti-vaccine rhetoric in the United States by the Government and it's supporters makes the future wary for vaccine stocks like MRNA , but I am entering a trade here based on the fact that their net income may be positive for next quarter, and it will be moreso of a long term trade spanning a couple of months. The lowest that I think it can rise to is $60, but it could go higher than that. Who knows. Worst Case is that It will go back down into to $20-30 range, but then again I am still optimistic that ( MRNA ) can turn things around. So we'll see. My cost basis for this trade is around 48.5, so that's alright for this stock. Trade active
Note
Looks to be heading towards the 37-40 range before Earnings, but we'll see if this stock will go up after earnings or I will be a bag holder like Chipotle. Note
Moderna just announced they had a deal with the Mexican Government, up 8% today. This is good and sets up for earnings. Note
RFK Nuked it. Looks like it isn't going to affect future revenues but still. Lmao.Still holding.
Note
We're close to earnings. Looks to be good but who knows.Note
MRNA beat earnings. This is great. They had better Revenue results and have a good outlook. We'll see from here, but this is great long term.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.